DYSF
Basic information
Region (hg38): 2:71453561-71686763
Previous symbols: [ "LGMD2B" ]
Links
Phenotypes
GenCC
Source:
- qualitative or quantitative defects of dysferlin (Definitive), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2B (Supportive), mode of inheritance: AR
- Miyoshi myopathy (Supportive), mode of inheritance: AR
- congenital myopathy, Paradas type (Supportive), mode of inheritance: AR
- distal myopathy with anterior tibial onset (Strong), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2B (Strong), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Miyoshi muscular dystrophy 1; Muscular dystrophy, limb-girdle, autosomal recessive, 2; Myopathy, distal, with anterior tibial onset | AR | Cardiovascular | Individuals may have mild cardiac anomalies, as well as more severe cardiac manifestations such as dilated cardiomyopathy, and surveillance (eg, with echocardiogram) may allow early detection and management of sequelae | Cardiovascular; Musculoskeletal | 3942856; 9009996; 8808603; 9731527; 9731526; 10196377; 10469840; 11134403; 10766988; 11198284; 16087766; 17287450; 17994539; 18306167; 19084402; 20535123; 21522182; 22297152; 22517428; 21816046 |
ClinVar
This is a list of variants' phenotypes submitted to
- Qualitative or quantitative defects of dysferlin (289 variants)
- not provided (137 variants)
- Miyoshi muscular dystrophy 1 (94 variants)
- Autosomal recessive limb-girdle muscular dystrophy type 2B (80 variants)
- Autosomal recessive limb-girdle muscular dystrophy (10 variants)
- Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B;Distal myopathy with anterior tibial onset (8 variants)
- Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B (6 variants)
- DYSF-related disorder (5 variants)
- Abnormality of the musculature (5 variants)
- Distal myopathy with anterior tibial onset (5 variants)
- Absent muscle fiber dysferlin;Foot dorsiflexor weakness;Peroneal muscle atrophy;Distal lower limb muscle weakness (1 variants)
- Proximal muscle weakness (1 variants)
- Miyoshi muscular dystrophy 1;Distal myopathy with anterior tibial onset;Autosomal recessive limb-girdle muscular dystrophy type 2B (1 variants)
- Autosomal recessive limb-girdle muscular dystrophy type 2B;Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1 (1 variants)
- Muscular dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DYSF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 869 | 892 | |||
missense | 18 | 59 | 765 | 68 | 915 | |
nonsense | 114 | 88 | 202 | |||
start loss | 2 | |||||
frameshift | 166 | 108 | 278 | |||
inframe indel | 27 | 31 | ||||
splice donor/acceptor (+/-2bp) | 57 | 98 | 160 | |||
splice region | 4 | 8 | 53 | 193 | 1 | 259 |
non coding | 29 | 637 | 152 | 822 | ||
Total | 359 | 357 | 843 | 1578 | 165 |
Highest pathogenic variant AF is 0.0000526
Variants in DYSF
This is a list of pathogenic ClinVar variants found in the DYSF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-71453672-G-T | Qualitative or quantitative defects of dysferlin | Conflicting classifications of pathogenicity (Nov 01, 2022) | ||
2-71453721-G-C | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jan 12, 2018) | ||
2-71453725-T-G | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jan 12, 2018) | ||
2-71453760-C-G | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jan 13, 2018) | ||
2-71453790-G-A | Likely benign (Nov 27, 2018) | |||
2-71453820-C-A | Qualitative or quantitative defects of dysferlin | Benign (Jun 19, 2018) | ||
2-71453949-T-A | not specified | Likely benign (Jul 19, 2017) | ||
2-71453955-C-T | not specified | Likely benign (Mar 20, 2017) | ||
2-71453965-G-T | not specified | Benign (Nov 07, 2017) | ||
2-71453987-C-G | not specified | Likely benign (Aug 17, 2017) | ||
2-71453992-G-A | Uncertain significance (Dec 22, 2017) | |||
2-71453999-A-G | Autosomal recessive limb-girdle muscular dystrophy type 2B | Likely pathogenic (Dec 07, 2017) | ||
2-71454000-T-C | Autosomal recessive limb-girdle muscular dystrophy type 2B • Qualitative or quantitative defects of dysferlin | Pathogenic/Likely pathogenic (Nov 12, 2023) | ||
2-71454002-C-T | not specified • Qualitative or quantitative defects of dysferlin | Conflicting classifications of pathogenicity (Jan 04, 2024) | ||
2-71454006-G-A | Uncertain significance (Jun 22, 2016) | |||
2-71454007-G-A | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 12, 2021) | ||
2-71454007-G-C | Qualitative or quantitative defects of dysferlin | Uncertain significance (Apr 22, 2022) | ||
2-71454009-T-G | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jul 14, 2022) | ||
2-71454015-T-A | Autosomal recessive limb-girdle muscular dystrophy type 2B • Qualitative or quantitative defects of dysferlin | Uncertain significance (Jul 18, 2022) | ||
2-71454016-C-T | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 08, 2022) | ||
2-71454017-C-T | Qualitative or quantitative defects of dysferlin | Uncertain significance (Sep 06, 2022) | ||
2-71454019-C-T | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 30, 2023) | ||
2-71454022-T-G | Qualitative or quantitative defects of dysferlin • Miyoshi muscular dystrophy 1 | Pathogenic/Likely pathogenic (Mar 24, 2024) | ||
2-71454023-G-A | Qualitative or quantitative defects of dysferlin | Uncertain significance (Aug 09, 2023) | ||
2-71454025-C-G | Qualitative or quantitative defects of dysferlin • Autosomal recessive limb-girdle muscular dystrophy type 2B | Likely benign (Jan 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DYSF | protein_coding | protein_coding | ENST00000410020 | 56 | 233047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.65e-33 | 1.00 | 125477 | 0 | 271 | 125748 | 0.00108 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0389 | 1232 | 1.24e+3 | 0.997 | 0.0000834 | 13861 |
Missense in Polyphen | 433 | 437.06 | 0.99071 | 4677 | ||
Synonymous | -1.86 | 551 | 498 | 1.11 | 0.0000338 | 4112 |
Loss of Function | 4.01 | 72 | 119 | 0.603 | 0.00000616 | 1350 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00446 | 0.00440 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00174 | 0.00174 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000854 | 0.000853 |
Middle Eastern | 0.00174 | 0.00174 |
South Asian | 0.00112 | 0.00111 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17185750, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:11959863, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.27}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Smooth Muscle Contraction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.307
Intolerance Scores
- loftool
- 0.00220
- rvis_EVS
- -1.31
- rvis_percentile_EVS
- 4.85
Haploinsufficiency Scores
- pHI
- 0.187
- hipred
- Y
- hipred_score
- 0.683
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.776
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dysf
- Phenotype
- muscle phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- dysf
- Affected structure
- muscle
- Phenotype tag
- abnormal
- Phenotype quality
- refractivity
Gene ontology
- Biological process
- angiogenesis;plasma membrane repair;positive regulation of endothelial cell proliferation;monocyte activation involved in immune response;macrophage activation involved in immune response;glycerol metabolic process;vesicle fusion;muscle contraction;negative regulation of gene expression;lipid storage;T-tubule organization;negative regulation of protein catabolic process;skeletal muscle tissue regeneration;fat cell differentiation;positive regulation of cell adhesion;muscle fiber development;cytokine secretion;negative regulation of phagocytosis;cellular response to osmotic stress;positive regulation of neutrophil chemotaxis;regulation of calcium ion import;negative regulation of high voltage-gated calcium channel activity;negative regulation of protein polyubiquitination
- Cellular component
- nucleus;endosome;early endosome;late endosome;Golgi apparatus;microtubule organizing center;microtubule;plasma membrane;integral component of membrane;lamellipodium;endocytic vesicle;T-tubule;cytoplasmic vesicle membrane;sarcolemma;extracellular exosome;membrane microdomain
- Molecular function
- calcium ion binding;protein binding;phospholipid binding;calcium-dependent phospholipid binding;microtubule binding;alpha-tubulin binding